Skip to main content

Table 4 Multivariate linear regression analyses displaying the impact of serum lnFABP4 levels on outcomes of lnISIM-cp, lnAUCcp/glu, lnGluca0min and lnAUCgluca in patients with T2D

From: Serum fatty acid-binding protein 4 levels and responses of pancreatic islet β-cells and α-cells in patients with type 2 diabetes

Models

β

t

p

Adjusted R2 for model

lnISIM-cp

 Model 0

 − 0.266

 − 2.886

0.005

0.062

 Model 1

 − 0.296

 − 2.900

0.005

0.391

lnAUCcp/glu

 Model 0

0.247

2.662

0.009

0.052

 Model 1

0.223

2.308

0.046

0.351

lnGluca0min

 Model 0

0.175

1.807

0.074

0.021

 Model 1

0.272

2.330

0.024

0.363

lnAUCgluca

 Model 0

0.304

3.240

0.002

0.084

 Model 1

0.341

3.065

0.004

0.407

  1. Model 0: unadjuseted
  2. Model 1: adjusted for age, gender, BMI, WC, diabetic duration, SBP, DBP, lipid profiles, eGFR, UA, FPG, HbA1c and glucose-lowering therapies